Experimental eye injection aims to halt vision loss in dry AMD
Disease control
Recruiting now
This early-stage study is testing whether a single injection called VOY-101 can slow the progression of advanced dry age-related macular degeneration (AMD), a condition that causes gradual central vision loss. Researchers will give increasing doses to 60 participants aged 60+ to …
Phase: PHASE1, PHASE2 • Sponsor: Perceive Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC